Skip to content
Microport Urocare logo — The Patient Always Comes First

Microport Urocare

The Patient Always Comes First

Founded 2016 China Shanghai, China 10 employees Post-IPO Equity Total: $1.30M Biotechnology, Health Care +1

General Information

Company Name Microport Urocare
Founded Year 2016
Location China Shanghai, China
Employees 10
Industries Biotechnology, Health Care, Manufacturing
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Microport Urocare. To contact Microport Urocare, visit microport.com.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Microport Urocare compare?

A PDF of Microport Urocare and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Microport Urocare soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Microport Urocare

Microport Urocare is a subsidiary of MicroPort Medical Science Co., Ltd. and has been committed to the R&D, production, and sales of interventional medical devices and consumables since its founding in 1998. The company operates in the fields of urology, gynecology, gastroenterology, and respiratory. Its R&D center is located in Shanghai, while its manufacturing base is situated in Jiaxing, Zhejiang Province, covering an extensive area of nearly 3,000 square meters. The company specializes in the development and launch of the single-use ureteroscope and various consumables, such as guidewires, stone retrieval baskets, and access sheaths, offering a comprehensive solution for kidney stone management. This innovative approach underscores their commitment to patient-centric care, as reflected in their slogan, "The Patient Always Comes First." The most recent investment was a Post-IPO Equity investment made on 02 August 2022, with participation from Shenzhen Capital Group and BOPU. With its focus on Biotechnology, Health Care, and Manufacturing, Microport Urocare continues to be a key player in the medical device industry, headquartered in China. For further details, inquiries can be directed to [email protected].

Business keywords: interventional medicine, minimally invasive, cardiovascular devices, vascular disease treatment, urology, gynecology, gastroenterology, respiratory devices, interventional medical devices, consumables, R&D, global expansion

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity Undisclosed 2
Shenzhen Capital Group, BOPU
02 Aug 2022
Series C $440.00K 1
Shenzhen Capital Group
01 Jul 2002
Series B $710.00K 1
Shenzhen Capital Group
01 May 2002
Series A $150.00K -
01 Nov 2001

Microport Urocare Alternatives & Competitors

View All Alternatives
Microport Urocare vs

Pathway Medical Technologies, Inc. was founded to design, market and manufacture medical devices for...

Venture round
32 employees
Health Care, Manufacturing
Microport Urocare vs

Our dNerva® Lung Denervation System is an investigative COPD therapy that aims to preserve patient l...

Venture round
32 employees
Biotechnology, Health Care
Microport Urocare vs

Creating minimally invasive solutions for aneurysms, providing a seamless blood flow to other arteri...

Series A
Biotechnology, Health Care

FAQ About Microport Urocare

The Patient Always Comes First
Microport Urocare was founded in 2016.
Microport Urocare is headquartered in Shanghai, China.
Microport Urocare operates in Biotechnology, Health Care and Manufacturing. Its work centres on interventional medicine, minimally invasive, cardiovascular devices and vascular disease treatment.
Microport Urocare has approximately 10 employees.
Microport Urocare has completed 4 funding rounds, raising a total of $1.30M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Microport Urocare include Pathway Medical Technologies, Nuvaira, Inc., TripleMed, MicroPort Endovastec, IceCure Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Microport Urocare and Pathway Medical Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Microport Urocare, https://bouncewatch.com/company/microport-urocare, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout